WHO ICTRP trial
A clinical trial to study the effects and safety of two drugs, Baricitinib and…
CTRI/2023/04/051790 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2023/04/051790 |
|---|---|
| Public title | A clinical trial to study the effects and safety of two drugs, Baricitinib and Mycophenolate mofetil in patients with skin thickening |
| Scientific title | A randomized controlled trial to compare the efficacy & safety of baricitinib with mycophenolate mofetil in systemic sclerosis. - BASIS |
| Primary sponsor | PGIMER pharmacy |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2/ Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: L948- Other specified localized connective tissue disorders |
| Interventions | Intervention1: Tablet Baricitinib 4 mg once a day, oral for 6 months: To compare the efficacy & safety of Baricitinib with Mycophenolate mofetil in systemic sclerosis Control Intervention1: Tablet Mycophenolate mofetil 1.5g twice a day… |
| Registration date | Apr 19, 2023 |
| Target size | 50 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: